Successful Hematopoietic Stem Cell Transplantation for Autosomal Recessive STAT1 Complete Deficiency

J Clin Immunol. 2021 Apr;41(3):684-687. doi: 10.1007/s10875-020-00948-7. Epub 2021 Jan 4.

Authors

Shuhei Karakawa¹, Maiko Shimomura², Sonoko Sakata², Tadashi Matsubayashi³, Satoshi Okada²

Affiliations

¹ Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Science, 1-2-3 Kasumi, Minami-Ku, Hiroshima-Shi, Hiroshima, 734-8551, Japan. kara1224@hiroshima-u.ac.jp.
² Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Science, 1-2-3 Kasumi, Minami-Ku, Hiroshima-Shi, Hiroshima, 734-8551, Japan.
³ Department of Pediatrics, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Disease Management
Genes, Recessive*
Genetic Predisposition to Disease*
Graft vs Host Disease / diagnosis
Graft vs Host Disease / etiology
Hematopoietic Stem Cell Transplantation* / adverse effects
Hematopoietic Stem Cell Transplantation* / methods
Humans
STAT1 Transcription Factor / deficiency*
Transplantation Conditioning / methods
Treatment Outcome

Substances

STAT1 Transcription Factor
STAT1 protein, human